Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Schultz-Fademrecht

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 5, 2009
Histone deacetylase inhibitors with a primary amide zinc binding group display antitumor activity in xenograft modelBarbara Attenni, Jesus M Ontoria, Jonathan C Cruz, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2009
Discovery and SAR of novel, potent and selective hexahydrobenzonaphthyridinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)Caterina Torrisi, Monica Bisbocci, Raffaele Ingenito, et al.
Journal of Medicinal Chemistry|June 3, 2014
Structure guided design and kinetic analysis of highly potent benzimidazole inhibitors targeting the PDEδ prenyl binding siteGunther Zimmermann, Carsten Schultz-Fademrecht, Philipp Küchler, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Synthesis and biological evaluation of substituted 2-phenyl-2H-indazole-7-carboxamides as potent poly(ADP-ribose) polymerase (PARP) inhibitorsRita Scarpelli, Julia K Boueres, Mauro Cerretani, et al.
Cell Chemical Biology|April 25, 2017
Covalent Protein Labeling at Glutamic AcidsPablo Martín-Gago, Eyad K Fansa, Michael Winzker, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2008
Optimization of a series of potent and selective ketone histone deacetylase inhibitorsGiovanna Pescatore, Olaf Kinzel, Barbara Attenni, et al.
Angewandte Chemie (International Ed. in English)|August 7, 2016
Insight into the Inhibition of Drug-Resistant Mutants of the Receptor Tyrosine Kinase EGFRJulian Engel, Christian Becker, Jonas Lategahn, et al.
Journal of Medicinal Chemistry|February 23, 2017
Indazole-Based Covalent Inhibitors To Target Drug-Resistant Epidermal Growth Factor ReceptorStefano Tomassi, Jonas Lategahn, Julian Engel, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 4, 2016
Development of Pyridazinone Chemotypes Targeting the PDEδ Prenyl Binding SiteSandip Murarka, Pablo Martín-Gago, Carsten Schultz-Fademrecht, et al.
Journal of Medicinal Chemistry|May 16, 2009
Discovery of a potent class I selective ketone histone deacetylase inhibitor with antitumor activity in vivo and optimized pharmacokinetic propertiesOlaf Kinzel, Laura Llauger-Bufi, Giovanna Pescatore, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|May 5, 2009
Histone deacetylase inhibitors with a primary amide zinc binding group display antitumor activity in xenograft modelBarbara Attenni, Jesus M Ontoria, Jonathan C Cruz, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2009
Discovery and SAR of novel, potent and selective hexahydrobenzonaphthyridinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)Caterina Torrisi, Monica Bisbocci, Raffaele Ingenito, et al.
Journal of Medicinal Chemistry|June 3, 2014
Structure guided design and kinetic analysis of highly potent benzimidazole inhibitors targeting the PDEδ prenyl binding siteGunther Zimmermann, Carsten Schultz-Fademrecht, Philipp Küchler, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Synthesis and biological evaluation of substituted 2-phenyl-2H-indazole-7-carboxamides as potent poly(ADP-ribose) polymerase (PARP) inhibitorsRita Scarpelli, Julia K Boueres, Mauro Cerretani, et al.
Cell Chemical Biology|April 25, 2017
Covalent Protein Labeling at Glutamic AcidsPablo Martín-Gago, Eyad K Fansa, Michael Winzker, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2008
Optimization of a series of potent and selective ketone histone deacetylase inhibitorsGiovanna Pescatore, Olaf Kinzel, Barbara Attenni, et al.
Angewandte Chemie (International Ed. in English)|August 7, 2016
Insight into the Inhibition of Drug-Resistant Mutants of the Receptor Tyrosine Kinase EGFRJulian Engel, Christian Becker, Jonas Lategahn, et al.
Journal of Medicinal Chemistry|February 23, 2017
Indazole-Based Covalent Inhibitors To Target Drug-Resistant Epidermal Growth Factor ReceptorStefano Tomassi, Jonas Lategahn, Julian Engel, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 4, 2016
Development of Pyridazinone Chemotypes Targeting the PDEδ Prenyl Binding SiteSandip Murarka, Pablo Martín-Gago, Carsten Schultz-Fademrecht, et al.
Journal of Medicinal Chemistry|May 16, 2009
Discovery of a potent class I selective ketone histone deacetylase inhibitor with antitumor activity in vivo and optimized pharmacokinetic propertiesOlaf Kinzel, Laura Llauger-Bufi, Giovanna Pescatore, et al.
Pageof 4